Helsinn seeks SCOTUS review of patent case

05-03-2018

Helsinn seeks SCOTUS review of patent case

ericsphotography / iStockphoto.com

Swiss-based pharmaceutical company Helsinn Healthcare has filed a petition for writ of certiorari with the US Supreme Court.


Helsinn Healthcare, Teva Pharmaceuticals, cancer, cancer treatment, US Court of Appeals for the Federal Circuit, Eisai, chemotherapy

LSIPR